U.S. jury clears Eli Lilly in first Cymbalta withdrawal trial

Aug 7 (Reuters) - Eli Lilly on Friday was cleared of liability in the first trial involving claims that its antidepressant Cymbalta caused severe withdrawal symptoms, including suicidal thoughts and electric shock-like sensations, the company said.